Summary
The effects of Δ9-tetrahydrocannabinol, (Δ9THC) the major psychoactive compound of marijuana, and cannabidiol (CBD), a non-psychoactive component, on the acetylcholine (ACh) concentration and the turnover rate of ACh (TRACh) have been studied in various regions of the rat brain. Neither Δ9THC doses from 0.2 to 10 mg/kg nor CBD (10 or 20 mg/kg) alter the ACh concentration in the brain areas examined 30 min, after the intravenous injection. However, Δ9-THC (doses from 0.2 to 10 mg/kg) causes a marked dose-related decrease in the TRACh in hippocampus whereas CBD is without effect in this brain region even when 20 mg/kg is given. Furthermore, high doses of Δ9-THC (5 mg/kg) and CBD (20 mg/kg) that produce a significant decrease in the TRACh of striatum fail to change the TRACh in parietal cortex. The low doses of Δ9-THC required to reduce hippocampal TRACh suggest that an action on these cholinergic mechanisms may play a role in the psychotomimetic activity of Δ9-THC.
Similar content being viewed by others
References
Ashew, W. E., Kimball, A. P., Ho, B. T.: Effect of tetrahydrocannabinols on brain acetylcholine. Brain Res. 69, 375–378 (1974)
Banerjee, S. P., Snyder, S. H., Mechoulam, R.: Cannabinoids: Influence on neurotransmitter uptake in rat brain synaptosomes. J. Pharmacol. Exp. Ther. 194, 74–81 (1975)
Brimblecombe, R. W.: Psychotomimetic drugs. Biochemistry and pharmacology. Advances Drug Res. 7, 165–206 (1973)
Brown, H.: Some anticholinergic-like behavioral effects of 109-1 tetrahydrocannabinol. Psychopharmacologia (Berl.) 21, 294–301 (1971)
Butcher, S. G., Butcher, L. L.: Origin and modulation of acetylcholine activity in the neostriatum. Brain Res. 71, 167–171 (1974)
Cavero, I., Buckley, J. P., Jandhyala, B. S.: Parasympatholytic activity of 109-2 in mongrel dogs. Eur. J. Pharmacol 19, 301–304 (1972)
Cheney, D. L., Trabucchi, M., Racagni, G., Wang, C., Costa, E.: Effects of acute and chronic morphine on regional rat brain acetylcholine turnover rate. Life Sci. 15, 1977–1990 (1974)
Consroe, P., Wolkin, A.: Cannabidiol-antiepileptic drug comparisons and interactions experimentally induced seizures in rats. Pharmacol. Exp. Ther. 201, 26–32 (1977)
Constantinidis, J., Miras, C. J.: Effect of hashish smoke sublimate on hypothalamic noradrenaline studied by the fluorescence method. Psychopharmacologia (Berl.) 22, 80–90 (1971)
Domino, E. F.: Neuropsychopharmacologic studies of marijuana: Some synthetic and natural THC derivatives in animals and man. Ann. N.Y. Acad. Sci. 191, 166–191 (1971)
Domino, E. F., Bartolini, A.: Effects of psychotomimetic agents on the EEG and acetylcholine release from the cerebral cortex of brainstem transected cats. Neuropharmacology 11, 703–713 (1972)
Dupont, R.: Marihuana: An issue comes of age. In: The pharmacology of marijuana (M. C. Braude and S. Szara, eds.), pp. 3–8. New York: Raven Press 1976
Edery, H., Gottesfeld, Z.: The γ-aminobutyric acid system in rat cerebellum during cannabinoid-induced cataleptoid state. Br. J. Pharmacol. 54, 406–408 (1975)
Fenessey, M. R., Taylor, D. A.: The effect of 109-3 on body temperature and brain amine concentrations in the rat at different ambient temperatures. Br. J. Pharmacol. 60, 65–71 (1977)
Frederickson, R. C. A., Hewes, C. R., Aiken, J. W.: Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: Their antagonism by 109-4. J. Pharmacol. Exp. Ther. 199, 375–384 (1976)
Friedman, E., Hanin, I., Gershon, S.: Effect of tetrahydrocannabinols on 3H-acetylcholine biosynthesis in various rat brain slices. J. Pharmacol. Exp. Ther. 196, 339–345 (1976)
Gallager, D. W., Sanders-Bush, E., Sulser, F.: Dissociation between behavioral effects and changes in metabolism of cerebral serotonin following 109-5. Psychopharmacologia (Berl.) 26, 337–345 (1972)
Gascon, A. L., Pérès, M. T.: Effect of 109-6 on the peripheral autonomic nervous system in vitro. Can. J. Physiol. Pharmacol. 51, 12–21 (1973)
Gill, E. W., Paton, W. D. M., Pertwee, R. G.: Preliminary experiments on the chemistry and pharmacology of cannabis. Nature (Lond.) 228, 134–136 (1970)
Guidotti, A., Cheney, D. L., Trabucchi, M., Doteuchi, M., Wang, C., Hawkins, R. A.: Focussed microwave radiation: A technique to minimize post mortem changes of cyclic nucleotides, DOPA and choline and to preserve brain morphology. Neuropharmacology 13, 1115–1122 (1974)
Hollister, L. E.: Cannabidiol and cannabinol in man. Experientia 29, 825–826 (1973)
Kemp, J. M., Powell, T. P. S.: The structure of the caudate nucleus of the cat: Light and electron microscopy. Philos. Trans. R. Soc. Lond. (Biol.) 262, 383–401 (1971)
Lewis, P. R., Shute, C. C. D.: The cholinergic limbic system: Projections to hippocampal formation, medial cortex, nuclei of the ascending cholinergic reticular system and the subfornical organ and supra-optic crest. Brain 90, 521–540 (1967)
Maitre, L., Staehelin, M., Bein, H. J.: Effect of an extract of cannabis and some cannabinols on catecholamine metabolism in rat brain and heart. Agents and Action 1, 136–143 (1970)
Mazurkiewicz-Kwilecki, I. M., Filczewski, M.: The effects of chronic treatment with 109-7 on catecholamine synthesis in the rat. Psychopharmacologia (Berl.) 33, 71–79 (1973)
Mechoulam, R., McCallum, N. K., Lander, N., Yagen, B., Ben-Zvi, Z., Levy, S.: Aspects of cannabis chemistry and metabolism. In: The pharmacology of marijuana (M. C. Braude and S. Szara, eds.), pp. 39–48. New York: Raven Press 1976
Moroni, F., Cheney, D. L., Costa, E.: β-Endorphin inhibits ACh turnover in nuclei of rat brain. Nature 267, 267–268 (1977a)
Moroni, F., Cheney, D. L., Costa, E.: Inhibition of acetylcholine turnover rate in rat hippocampus by intraseptal injection of β-endorphin and morphine. Naunyn-Schmiedeberg's Arch. Pharmacol 299, 149–153 (1977b)
Pepeu, G., Bartolini, A.: Effect of psychoactive drugs on the output of acetylcholine from the cerebral cortex of the cat. Eur. J. Pharmacol. 4, 254–263 (1968)
Racagni, C., Cheney, D. L., Trabucchi, M., Wang, C., Costa, E.: Measurement of acetylcholine turnover rate in discrete areas of rat brain. Life Sci 15, 1961–1975 (1974)
Schildkraut, J. J., Efron, D. H.: The effects of 110-1 on the metabolism of norepinephrine in trat brain. Psychopharmacologia (Berl.) 20, 191–196 (1971)
Sofia, R. D., Kubena, R. K., Barry, H., III.: Comparison of four vehicles for intraperitoneal administration of 110-2 J. Pharm. Pharmacol. 23, 889–891 (1971)
Sofia, R. D., Solomon, T. A., Barry, H., III.: Anticonvulsant activity of 110-3 compared with three other drugs. Eur. J. Pharmacol. 35, 7–16 (1976)
Zsilla, G., Racagni, G., Cheney, D. L., Costa, E.: Constant rate infusion of deuterated phosphorylcholine to measure the effects of morphine on acetylcholine turnover rate in specific nuclei of rat brain. Neuropharmacology 16, 25–30 (1977)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Revuelta, A.V., Moroni, F., Cheney, D.L. et al. Effect of cannabinoids on the turnover rate of acetylcholine in rat hippocampus, striatum and cortex. Naunyn-Schmiedeberg's Arch. Pharmacol. 304, 107–110 (1978). https://doi.org/10.1007/BF00495546
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00495546